Matthew Reynolds to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Matthew Reynolds has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.163
-
Cannon CP, Khan I, Klimchak AC, Sanchez RJ, Sasiela WJ, Massaro JM, D'Agostino RB, Reynolds MR. Simulation of impact on cardiovascular events due to lipid-lowering therapy intensification in a population with atherosclerotic cardiovascular disease. Am Heart J. 2019 10; 216:30-41.
Score: 0.134
-
Cannon CP, Khan I, Klimchak AC, Reynolds MR, Sanchez RJ, Sasiela WJ. Simulation of Lipid-Lowering Therapy Intensification in a Population With Atherosclerotic Cardiovascular Disease. JAMA Cardiol. 2017 09 01; 2(9):959-966.
Score: 0.030